Eli Lilly’s latest Alzheimer’s drug may be next to receive FDA approval. But investors should know about some of the hurdles ahead.
You are here: Home / Eli Lilly has spent years and billions of dollars in search of an effective Alzheimer’s drug. But success is not all or nothing for the stock